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Background: Limited recent data are available describing differences in long-term survival, 
and factors affecting prognosis, after ST-segment elevation myocardial infarction (STEMI) and 
non-ST-segment elevation myocardial infarction (NSTEMI), especially from the more gener-
alizable perspective of a population-based investigation. The objectives of this study were to 
examine differences in post-discharge prognosis after hospitalization for STEMI and NSTEMI, 
with a particular focus on factors associated with reduced long-term survival.
Methods: We reviewed the medical records of residents of the Worcester, MA, USA 
metropolitan area hospitalized at eleven central Massachusetts medical centers for acute 
myocardial infarction (AMI) during 2001, 2003, 2005, and 2007.
Results: A total of 3762 persons were hospitalized with confirmed AMI; of these, 2539 patients 
(67.5%) were diagnosed with NSTEMI. The average age of study patients was 70.3 years and 
42.9% were women. Patients with NSTEMI experienced higher post-discharge death rates with 
3-month, 1-year, and 2-year death rates of 12.6%, 23.5%, and 33.2%, respectively, compared 
to 6.1%, 11.5%, and 16.4% for patients with STEMI. After multivariable adjustment, patients 
with NSTEMI were significantly more likely to have died after hospital discharge (adjusted 
hazards ratio 1.28; 95% confidence interval 1.14–1.44). Several demographic (eg, older age) 
and clinical (eg, history of stroke) factors were associated with reduced long-term survival in 
patients with NSTEMI and STEMI.
Conclusions: The results of this study in residents of central Massachusetts suggest that patients 
with NSTEMI are at higher risk for dying after hospital discharge, and several subgroups are 
at particularly increased risk.
Keywords: temporal trends, community-based study, STEMI/NSTEMI
Introduction
Approximately 1 million new and recurrent acute myocardial infarctions (AMI) occur 
annually in the United States.1 Whereas ST-segment elevation myocardial infarction 
(STEMI) has long been accepted terminology in the literature and clinical setting,2 
the term non-STEMI (NSTEMI) became more commonly used in the mid-1990s.3,4 
Classifying patients with AMI into STEMI and NSTEMI has clinical utility since each 
group is comprised of patients with unique clinical characteristics, different treatment 
approaches, and in-hospital and short-term survival.5–8
Data from randomized trials have shown that hospitalized patients with NSTEMI 
have a lower risk of dying during the first few weeks after an AMI, but are at higher 
risk for adverse cardiovascular outcomes over the long-term than patients with a 
STEMI.9,10 However, data derived from clinical trials may lack generalizability since 
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these study populations generally include younger and 
healthier individuals than are commonly seen in community-
based investigations. Some investigations have reported no 
differences in 1-year mortality rates between STEMI and 
NSTEMI patients,6 whereas others have observed higher 
death rates for patients with STEMI or for those with 
NSTEMI.7,8 These divergent findings may be explained in 
part by the different sociodemographic and clinical charac-
teristics of AMI patients being studied as well as to sampling 
and methodologic approaches utilized to identify the popula-
tion of interest.
We have previously described the in-hospital and 1-year 
death rates in patients with NSTEMI and STEMI,11 but more 
data are needed to delineate the longer-term prognosis of 
patients with these two major types of AMI, particularly 
from a more generalizable population-based perspective. 
Moreover, few recent studies have examined what factors 
may be associated with post-discharge mortality in these 
patients and whether these prognostic factors differ between 
patients with STEMI or NSTEMI.6–8
The objectives of this study were to describe relatively 
contemporary post-hospital discharge all-cause death rates, 
and factors associated with an increased risk of dying, in 
patients who were discharged after an AMI from all central 
Massachusetts hospitals in the 2000s, further classified 
according to AMI type. Data from the Worcester Heart 
Attack Study (WHAS), an ongoing, population-based 
investigation describing the clinical epidemiology of AMI in 
residents of central Massachusetts, were used in the present 
investigation.11–13
Methods
The WHAS has been collecting data describing the clinical 
epidemiology of AMI in residents of the Worcester, MA, 
USA metropolitan area hospitalized at all eleven central 
Massachusetts medical centers on an approximate alternat-
ing yearly basis.11–13 For the present study, we included 
data from only the most recent hospitalized patient cohorts, 
namely 2001, 2003, 2005, and 2007, in order to describe 
overall differences, and recent trends, in the epidemiology 
of STEMI and NSTEMI in this large central New England 
population. Of the 4208 patients hospitalized during the 
period under study, 435 died during hospitalization and 
eleven were lacking information on post-discharge survival. 
These 446 cases were excluded from the present study. This 
study was approved by the Committee for the Protection of 
Human Subjects at the University of Massachusetts  Medical 
School.
Study population
The methodology of the WHAS has been described elsewhere 
in detail.11–13 In brief, the medical records of patients at each 
central Massachusetts medical center who were hospital-
ized for possible AMI were reviewed by trained nurses and 
physicians and were validated according to predetermined 
criteria.
Patients with STEMI and NSTEMI were classified 
according to standardized diagnostic criteria that we have 
used in this study on an ongoing basis.11 A diagnosis of 
STEMI was made when new ST-segment elevation was 
present at the J point in two or more contiguous leads. 
A diagnosis of NSTEMI was accepted when, in the absence 
of ST-segment elevation, ischemic ST-segment or T wave 
changes were present for at least 24 hours with positive 
cardiac enzymes and/or a typical clinical presentation. 
From 2003 on, in the absence of electrocardiogram (ECG) 
abnormalities, a diagnosis of NSTEMI was accepted 
when elevations in various cardiac biomarker assays, 
including troponin, were accompanied by typical clinical 
presentation.
Trained nurse and physician study personnel reviewed all 
baseline and serial ECGs and quality control activities were 
routinely conducted with respect to ECG interpretation and 
abstraction of data from hospital medical records. Computer 
systems at all greater Worcester hospitals also over-read all 
ECGs and were independently reviewed by trained study 
personnel. We excluded cases of AMI that developed in 
the setting of trauma, as a result of a noncardiac condition, 
in the perioperative period, as well as cases of AMI which 
occurred in patients who did not reside in the Worcester 
metropolitan area.
Data collection
Sociodemographic, medical history, laboratory, and clinical 
data were abstracted from the hospital medical records of 
eligible patients.11–13 Patients were classified as having an 
initial AMI based on the review of information contained 
in hospital medical records and the absence of a history 
of prior coronary disease.12,13 Information on the develop-
ment of important inpatient clinical complications was also 
collected based on the review of hospital medical records. 
These complications included atrial fibrillation, heart failure, 
cardiogenic shock, and stroke; uniform working definitions 
of each of these complications were defined in a standard-
ized manner.14–17
Post-discharge mortality data were collected through the 
review of state and Social Security death certificates as well 
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as by reviewing medical records for subsequent readmissions. 
Our primary study end point was all-cause mortality.
Data analysis
We examined differences in the characteristics of patients 
discharged from all greater Worcester hospitals with STEMI 
versus NSTEMI by utilizing t-tests for continuous variables 
and Chi-square tests for categorical variables. We examined 
post-discharge survival through 2009, accounting for the 
varying length of time patients were followed after hospital 
discharge. A Cox proportional hazards regression approach 
was utilized to examine the independent association between 
selected demographic and clinical factors with post-discharge 
mortality over the period of follow-up. Variables were 
included in this regression model based on a P-value of 
#0.15 as well as on previously published associations with 
these factors on long-term prognosis after AMI. Variables 
associated with high rates of missing data, which occurred 
for ejection fraction, serum lipids, and body mass index, were 
not included in our regression models. Post-discharge socio-
demographic, clinical, or medical care related variables were 
not included in our regression models since we did not collect 
further information about these prognostic factors. Hazard 
ratios (HRs) and accompanying 95% confidence intervals 
(CIs) around various point estimates, including overall dif-
ferences in long-term survival between patients with STEMI 
and NSTEMI, were calculated in a standardized manner. 
Using the graphical and numerical methods for model assess-
ment we found that the assumption of proportional hazards 
was violated by two clinically relevant factors.18 Inasmuch, 
we conducted a sensitivity analysis using an accelerated 
failure time model to confirm the validity of the Cox model 
in light of the presence of nonproportional hazards among 
these key study covariates – prior medical history of heart 
failure and systolic blood pressure findings at the time of 
hospital admission. We added the P-values from this model 
to Table 2. This analysis confirmed that the violation of the 
proportional hazards assumption did not affect the reliability 
of our results. A logistic regression analysis was also carried 
out for purposes of examining differences in post-discharge 
prognosis at key long-term points (eg, 3 months, 1 year, 
2 years) between patients with STEMI versus NSTEMI, with 
odds ratios (ORs) and accompanying 95% CIs calculated.
Results
Characteristics of study population
A total of 3762 individuals with confirmed AMI were dis-
charged from all metropolitan Worcester hospitals between 
2001 and 2007. The average age of study patients was 
70.3 years and 42.9% were women. Of these, 2539 patients 
(67.5%) were diagnosed with NSTEMI.
Patients with NSTEMI were significantly older, included 
a greater proportion of women,  and had more comorbid 
cardiovascular conditions, but were less likely to have pre-
sented with an initial AMI compared to patients with STEMI 
(Table 1). The hospital course of patients with NSTEMI was 
more likely to have been complicated by the development 
of atrial fibrillation and heart failure (Table 1). Patients with 
NSTEMI had higher systolic blood pressure and serum glu-
cose levels, and lower estimated glomerular filtration rate 
(GFR) findings, than patients with STEMI.
Expectedly, patients with STEMI were more likely 
to have undergone a percutaneous coronary intervention 
(PCI), whereas coronary artery bypass graft (CABG) sur-
gery was performed in a similar percentage of both patient 
groups. Patients with NSTEMI were more likely to have 
been discharged from the hospital on digoxin and calcium 
channel blockers, while patients with STEMI were more 
likely to have been discharged on aspirin, beta-blockers, 
lipid-lowering agents, and angiotensin-converting-enzyme 
(ACE)-inhibitors/angiotensin receptor blockers.
Post-hospital discharge prognosis
Patients discharged from greater Worcester hospitals after 
NSTEMI during the years under study experienced higher 
post-discharge all-cause death rates with 3-month, 1-year, and 
2-year death rates of 12.6%, 23.5%, and 33.2%, respectively, 
compared with 6.1%, 11.5%, and 16.4% for patients with 
STEMI (Figure 1). For our initial two study cohorts (2001 
and 2003) in which longer-term follow-up was available, the 
5-year death rates were 30.2% and 52.4%, respectively, for 
patients with STEMI and NSTEMI (Figure 1).
After adjusting for baseline differences in age, sex, length 
of stay, comorbidities, hospital clinical complications, and 
physiologic variables, patients with STEMI were significantly 
more likely to have survived at 3 months (OR 1.38; 95% CI 
1.01–1.87), 1 year (OR 1.38; 95% CI 1.09–1.74), and 2 years 
(OR 1.53; 95% CI 1.23–1.89) (all P-values ,0.05) after hos-
pital discharge compared to patients with NSTEMI. Overall, 
patients with NSTEMI were significantly more likely to have 
died during the years under study than patients with STEMI 
(adjusted HR = 1.28; 95% CI 1.14–1.44) (P-value ,0.05).
Since early coronary revascularization is recommended 
for patients with STEMI, we carried out an additional sub-
group analysis in which we examined differences in post 
discharge death rates in patients with STEMI and NSTEMI 
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who underwent either PCI or CABG. The results of this 
crude unadjusted analysis revealed death rates of 3.1% 
versus 3.2% at 3 months, 6.0% versus 8.4% at 1 year, and 
7.9% versus 12.8% at 2 years in patients with STEMI versus 
NSTEMI, respectively, in patients who underwent coronary 
revascularization.
Factors associated with post-hospital 
discharge prognosis
After multivariate adjustment for the sociodemographic char-
acteristics, comorbidities, hospital clinical complications, and 
admission physiologic variables included in Table 1, factors 
significantly associated with an adverse long-term progno-
sis following hospital discharge for patients with STEMI 
included older age, longer hospital stay, previously diagnosed 
heart failure, diabetes or stroke, development of atrial fibril-
lation during hospitalization, elevated systolic blood pressure 
and blood glucose findings at the time of hospital admission, 
and lower serum estimated GFR findings (Table 2). Among 
patients with NSTEMI, older individuals, men, those with a 
longer hospital stay, patients with a history of either stroke, 
heart failure, or diabetes, and those who developed stroke or 
Table 1 Characteristics of patients with AMi according to type of AMi
STEMI 
(n = 1223)
NSTEMI 
(n = 2539)
P-value
Demographics
 Age (mean, years) (SD) 65.5 (14.3) 72.6 (13.6) ,0.001
 Body mass index (mean) 28.1 (5.8) 27.9 (6.2) 0.40
Length of hospital stay (mean, days) (SD) 5.5 (5.1) 5.9 (6.2) 0.08
n (%) n (%)
 Male 778 (63.6) 1370 (54.0) ,0.001
 White race 1093 (89.4) 2259 (89.0) 0.71
Medical history
  Atrial fibrillation 86 (7.0) 422 (16.6) ,0.001
 Diabetes 305 (25.0) 952 (37.5) ,0.001
 Heart failure 140 (11.5) 746 (29.4) ,0.001
 Hypertension 765 (62.6) 1967 (77.5) ,0.001
 Renal disease 145 (11.9) 541 (21.3) ,0.001
 Stroke 85 (7.0) 338 (13.3) ,0.001
initial Mi 913 (74.7) 1539 (60.6) ,0.001
Hospital clinical complications n (%) n (%)
  Atrial fibrillation 209 (17.1) 543 (21.4) ,0.01
 Heart failure 350 (28.6) 1050 (41.4) ,0.001
 Cardiogenic shock 81 (6.6) 48 (1.9) ,0.001
 Stroke 11 (0.9) 32 (1.3) 0.33
Physiologic variables at hospital admission                 mean (SD)
 Systolic blood pressure (mmHg) 139.0 (31.3) 145.8 (32.9) ,0.001
 Diastolic blood pressure (mmHg) 78.9 (20.6) 77.1 (20.5) 0.02
 Glucose (mg/dL) 170.0 (85.5) 177.8 (108.7) 0.03
 Total cholesterol (mg/dL) 176.4 (47.1) 172.8 (52.9) 0.10
  Glomerular filtration rate (mL/min/1.73 m2) 67.0 (26.5) 56.9 (24.2) ,0.001
 Ejection fraction (%) 46.2 (12.9) 47.2 (14.1) 0.11
Medications at time of discharge n (%) n (%)
 Aspirin 1085 (88.7) 2111 (83.1) ,0.001
 Beta-blocker 1066 (87.2) 2108 (83.0) ,0.001
 Anticoagulants 177 (14.5) 426 (16.8) 0.07
 ACE-inhibitor or angiotensin receptor blocker 836 (68.4) 1469 (57.9) ,0.001
 Calcium channel blocker 87 (7.1) 450 (17.7) ,0.001
 Digoxin 112 (9.2) 407 (16.0) ,0.001
 Lipid lowering agents 908 (74.2) 1696 (66.8) ,0.001
Procedures during hospitalization
 Percutaneous coronary intervention 807 (66.0) 841 (33.1) ,0.001
 Coronary bypass graft surgery 86 (7.0) 168 (6.6) 0.63
Abbreviations: ACE, angiotensin-converting-enzyme; AMi, acute myocardial infarction; Mi, myocardial infarction; NSTEMi, non-ST-segment elevation myocardial infarction; 
SD, standard deviation; STEMi, ST-segment elevation myocardial infarction.
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Table 2 Factors associated with post-discharge mortality according to type of AMi
Factor STEMI NSTEMI
Hazard 
ratio
95% CI P-value* Hazard 
ratio
95% CI P-value*
Age (per 10 year increase) 1.66 1.51–1.82 ,0.001 1.76 1.66–1.87 ,0.001
Male 1.14 0.92–1.42 0.35 1.24 1.10–1.38 ,0.01
Length of stay (days) 1.03 1.01–1.05 ,0.001 1.00 1.00–1.02 ,0.01
Comorbidities
 Hypertension 1.01 0.80–1.28 0.60 0.93 0.80–1.07 ,0.01
  Atrial fibrillation 1.25 0.91–1.71 0.23 1.13 0.98–1.30 0.57
 Stroke 1.42 1.04–1.94 ,0.05 1.45 1.26–1.67 ,0.01
 Congestive heart failure 1.82 1.38–2.39 ,0.01 1.72 1.51–1.95 ,0.001
 Diabetes 1.21 0.95–1.54 ,0.05 1.26 1.11–1.43 ,0.05
 Renal disease 1.22 0.92–1.61 0.67 1.27 1.11–1.46 0.33
 Myocardial infarction 0.98 0.79–1.23 0.63 0.91 0.81–1.01 0.69
Hospital complications
  Atrial fibrillation 1.34 1.05–1.71 ,0.05 1.01 0.89–1.16 0.10
 Stroke 1.27 0.64–2.54 0.49 1.38 0.94–2.03 ,0.01
 Cardiogenic shock 0.83 0.55–1.25 0.34 1.35 0.95–1.92 0.71
 Heart failure 1.06 0.84–1.34 0.86 1.45 1.28–1.64 ,0.001
Admission physiologic variables
Systolic blood pressure (per 10 mmHg increase) 0.99 0.96–1.02 ,0.05 0.97 0.96–0.99 ,0.05
Estimated glomerular filtration rate (mL/min/1.73 m2)
  ,30 2.68 1.88–3.82 ,0.001 2.04 1.69–2.46 ,0.001
  30–59 1.40 1.11–1.77 0.34 1.23 1.07–1.41 ,0.01
Elevated blood glucose levels (per 10 mg/dL increase) 1.02 1.01–1.03 ,0.01 1.00 1.00–1.01 ,0.05
Note: *P-value from accelerated failure time model.
Abbreviations:  AMI,  acute  myocardial  infarction;  CI,  confidence  interval;  NSTEMI,  non-ST-segment  elevation  myocardial  infarction;  STEMI,  ST-segment  elevation 
myocardial infarction.
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Figure 1 Post-discharge survival of patients according to type of AMi for patients enrolled in the Worcester Heart Attack Study in 2001, 2003, 2005, and 2007.
Note: Worcester Heart Attack Study data from.11,12,14
Abbreviations: AMi, acute myocardial infarction; NSTEMi, non-ST-segment elevation myocardial infarction; STEMi, ST-segment elevation myocardial infarction.
heart failure during hospitalization were at greater risk for 
dying than respective comparison groups. Elevated systolic 
blood pressure and elevated blood glucose levels at the time 
of hospital presentation as well as lower serum estimated 
GFR findings were associated with decreased long-term 
mortality following NSTEMI (Table 2).
Discussion
The results of this community-based study demonstrate that 
the post-discharge death rates for patients hospitalized with 
NSTEMI were higher than for patients discharged after 
STEMI. After multivariate adjustment, increasing age was 
an important predictor of death for both patient groups after 
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hospital discharge, whereas several factors were differentially 
associated with mortality depending on AMI type.
Similar to the results of other studies,6,7,19 a previous 
publication from the WHAS showed that patients with 
NSTEMI were at higher risk for dying during the first year 
after hospital discharge.11 In the multicenter registry of more 
than 2100 patients hospitalized with an AMI at 56 centers 
throughout France,6 patients with NSTEMI experienced 
higher post-discharge death rates as well as rates of rehospi-
talization than patients with STEMI. Among a large cohort 
of patients undergoing cardiac catheterization between 1999 
and 2007 at Duke University Medical Center, patients who 
developed NSTEMI experienced a higher risk of dying over 
the long-term (median follow-up = 4 years) than patients 
with STEMI.7 Similarly, when we extended our period of 
follow-up even further to 5 years after hospital discharge, 
patients with NSTEMI continued to fare appreciably worse 
over the long-term.
It has been previously reported that patients with STEMI 
are treated more aggressively with various inpatient thera-
pies that are not based on disease severity.6 We similarly 
observed differences in the receipt of inpatient procedures 
and discharge medications according to AMI type. While 
these treatment practices may be accounted for by differen-
tial indications and current practice guidelines, it is possible 
that differences in treatment may have partially accounted 
for the improved long-term survival we observed in patients 
with STEMI. We did not, however, control for the receipt 
of either cardiac medications or coronary revascularization 
procedures in our regression models due to the significant 
potential for confounding by treatment indication in the 
context of this nonrandomized observational study. When 
we did, however, carry out a subgroup analysis in patients 
who underwent either a PCI or CABG surgery during hos-
pitalization, patients with NSTEMI continued to experience 
higher all-cause death rates over our follow-up period than 
patients with STEMI.
The 1-year all-cause mortality rates for patients dis-
charged from greater Worcester hospitals after STEMI 
(12%) and NSTEMI (24%) were slightly higher for STEMI, 
but considerably higher for NSTEMI, than what has been 
reported in prior investigations. A single-center observational 
study of patients with myocardial infarction undergoing PCI 
reported 1-year death rates of 9.5% and 14.3% for STEMI and 
NSTEMI, respectively.7 A study of 1486 patients with AMI 
enrolled in the multicenter Dynamic Registry observed 1-year 
mortality rates of 7.3% for STEMI and 5.5% for NSTEMI,20 
while the 1-year death rates were 9.0% in STEMI patients and 
11.6% in NSTEMI patients in the OPERA registry.6 In the 
GUSTO-IIb trial, 1-year death rates were 9.6% for patients 
with STEMI and 11.1% for those with NSTEMI.19
The discrepancies between these results and our findings 
are likely attributable to the advanced age and comorbid 
disease burden of patients in our community-based study as 
compared with those enrolled in other studies with different 
methodologies and more restrictive inclusion criteria,19 or 
only patients studied at specialized medical centers.7 Our 
findings may be more generalizable to the overall population 
of patients experiencing an AMI, and are important as they 
help to resolve the discrepancies in the results between other 
studies performed over a similar time period in more select 
patient populations.7,20 The present results lend further sup-
port to the notion that patients discharged from the hospital 
after NSTEMI constitute a high risk group in whom close 
surveillance and the use of evidence-based cardiac medica-
tions, where appropriate, is warranted.
Factors associated with increased 
mortality
In a multicenter study of patients hospitalized with AMI 
at 56 centers in France in the early 2000s, while advanced 
age, high heart rate on admission, and low levels of blood 
pressure at the time of hospital admission were independent, 
and similar, correlates of 1-year death rates in patients with 
STEMI or NSTEMI, differences in the predictability of sev-
eral factors, or their strength of association, were observed 
in patients according to type of AMI.6
Results of prior studies examining the association 
between sex and mortality after AMI have been conflicting, 
especially after controlling for age.21,22 In the present study, 
men were more likely to have died after hospital discharge 
for NSTEMI and STEMI.
Another important prognostic factor was the presence 
of renal dysfunction, which was associated with long-term 
mortality in both patient groups. Similarly, prior studies have 
demonstrated higher in-hospital, 30-day, and 3-year mortality 
rates in patients with AMI and renal impairment as compared 
to those with intact renal function.23,24 Renal impairment may 
increase mortality through multiple mechanisms, including a 
decreased likelihood of receiving appropriate therapies due to 
concern over an increased risk of bleeding or worsening renal 
function, drug toxicity, and endothelial dysfunction.23,24
The long-term mortality for patients with NSTEMI, in 
particular, has been related to the extent of their comor-
bid disease burden.25 In the present study, patients with 
NSTEMI were more likely to have several comorbid diseases 
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 previously diagnosed, but patients with NSTEMI and STEMI 
were both found to have decreased survival if they had a 
history of heart failure. This is not surprising given the dis-
mal long-term prognosis that is associated with this clinical 
syndrome.26 Similarly, we found that a history of prior stroke 
was associated with decreased survival in both patient groups 
after hospital discharge. This finding is consistent with prior 
reports where AMI patients with prior stroke were treated 
less aggressively, and had higher rates of complications and 
inpatient and early post-discharge mortality, than patients 
without previously diagnosed stroke.27
Interestingly, we found that patients with NSTEMI 
who presented with an elevated systolic blood pressure had 
reduced mortality. A registry study in Sweden also found 
that, among patients admitted to the intensive care unit with 
AMI, an elevated blood pressure was associated with reduced 
1-year mortality.28 Why a higher systolic blood pressure 
might be associated with improved outcomes for patients 
with AMI is unknown, but may reflect preserved myocardial 
function or absence of systemic hypoperfusion.
Despite similarities in some prognostic factors, there 
were also differences in the prognostic impact of several 
physiologic variables and in-hospital clinical complications 
between patients with STEMI and NSTEMI, with a number 
of these factors having a particularly adverse impact in those 
with NSTEMI. These findings suggest the need for greater 
surveillance, and intervention where appropriate, for high 
risk patients with NSTEMI.
Study strengths and limitations
The strengths of this study include its community-based 
perspective, its relatively contemporary population of 
patients hospitalized with AMI, and its large sample size. 
Our study has several limitations, however, that should 
be considered when interpreting the present results. The 
greater Worcester population is predominantly Caucasian 
and our findings may lack generalizability to other ethnic 
groups or communities of varying size. We were not able to 
comment on the influence that hospital and post-discharge 
treatment practices may have had on long-term prognosis 
since this was a nonrandomized observational study and 
we did not collect information about the receipt of different 
medication treatment regimens or coronary revasculariza-
tion approaches after a patient’s discharge from all central 
Massachusetts hospitals. We were unable to further classify 
patients with AMI into a recently recommended schema29 
and to satisfactorily assess, and by extension, analytically 
control for, other potentially important factors that may 
have influenced prognosis after AMI, such as infarct size, 
serum lipid or blood pressure levels, or presence of adverse 
lifestyle practices, such as cigarette smoking.
Conclusion
In this relatively contemporary cohort, patients with STEMI 
experienced a better post-discharge prognosis than those with 
NSTEMI. The factors associated with increased mortality for 
each of these patient groups were somewhat distinct, empha-
sizing the uniqueness of each disease category. Additional 
population-based surveillance efforts are needed to monitor 
recent trends in the natural history, functional status, and 
quality of life in patients further classified according to 
type of AMI. Studies leading to better understanding of the 
optimal inpatient and outpatient treatments based on AMI 
type and comorbid disease burden may maximize long-term 
outcomes for these patients.
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